Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax
- 7 October 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (41) , 5703-5713
- https://doi.org/10.1038/sj.onc.1202966
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 52 references indexed in Scilit:
- Generation of Fiber-Mutant Recombinant Adenoviruses for Gene Therapy of Malignant GliomaHuman Gene Therapy, 1998
- Apoptosis by Retrovirus- and Adenovirus-Mediated Gene Transfer of Fas Ligand to Glioma Cells: Implications for Gene TherapyHuman Gene Therapy, 1998
- Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosisOncogene, 1998
- Movement of Bax from the Cytosol to Mitochondria during ApoptosisThe Journal of cell biology, 1997
- The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell deathOncogene, 1997
- Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ-cell tumor cell line NT2, as quantitated by flow cytometryCytometry, 1997
- Adenovirus-Mediated Inducible Gene Expression through Tetracycline-Controllable Transactivator with Nuclear Localization SignalBiochemical and Biophysical Research Communications, 1997
- An Alternatively Spliced C. elegans ced-4 RNA Encodes a Novel Cell Death InhibitorCell, 1996
- Bax-independent inhibition of apoptosis by Bcl-XLNature, 1996
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993